V-Square Quantitative Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$21.4M Buy
18,530
+1,536
+9% +$1.81M 1.97% 6
2026
Q2
$20.4M Sell
16,994
-271
-2% -$277K 1.94% 6
2026
Q1
$15.9M Buy
17,265
+446
+3% +$452K 1.68% 7
2025
Q4
$18.1M Buy
16,819
+187
+1% +$179K 1.88% 7
2025
Q3
$12.7M Buy
16,632
+1,083
+7% +$806K 2.14% 8
2025
Q2
$12.1M Sell
15,549
-177
-1% -$138K 1.62% 8
2025
Q1
$13M Buy
15,726
+874
+6% +$727K 1.9% 5
2024
Q4
$11.5M Buy
14,852
+684
+5% +$566K 1.63% 6
2024
Q3
$12.6M Buy
14,168
+1,266
+10% +$1.14M 1.84% 5
2024
Q2
$11.7M Buy
12,902
+121
+0.9% +$96.8K 1.89% 6
2024
Q1
$9.9M Buy
12,781
+3,453
+37% +$2.46M 1.39% 6
2023
Q4
$5.44M Buy
9,328
+3,568
+62% +$2.08M 0.96% 8
2023
Q3
$3.09M Buy
5,760
+837
+17% +$431K 1.36% 6
2023
Q2
$2.31M Sell
4,923
-1,998
-29% -$838K 1.68% 8
2023
Q1
$2.38M Buy
+6,921
New +$2.33M 2.19% 7

Other funds holding LLY

V-Square Quantitative Management's LLY Position: Q3 2026 in Review

V-Square Quantitative Management increased its Eli Lilly (LLY) stake by 9% in Q3 2026, buying an estimated $1.81M and bringing the position to 18,530 shares worth $21.4M. The position accounts for 1.97% of the portfolio, ranked #6.

V-Square Quantitative Management first reported a position in LLY in Q1 2023 and has held it in 15 quarters since. 960 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • V-Square Quantitative Management held 18,530 shares of Eli Lilly worth $21.4M as of Q3 2026.
  • V-Square Quantitative Management bought 1,536 Eli Lilly shares in Q3 2026, an estimated $1.81M.
  • Eli Lilly made up 1.97% of V-Square Quantitative Management's portfolio in Q3 2026, its #6 holding.
  • V-Square Quantitative Management first reported a position in Eli Lilly in Q1 2023 and has held it in 15 quarters since.
  • 960 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on V-Square Quantitative Management's 13F filing for Q3 2026, filed 15 Oct 2026.